Amrutanjan Health Care Ltd - 590006 - Audited Financial Results For The Quarter And Year Ended 31/03/2021
Audited Financial Results for the quarter and year ended 31/03/202127-05-2021
27-05-2021
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Director Appointment
In compliance of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulation, 2015, we wish to inform you that the Board of Directors, at its Meeting held on 27th May 2021, has: 1) Approved the appointment of Mr Raja Venkataraman (DIN: 00669376) as an Additional Director (Non-Executive, Independent) with effect from 27/05/2021, to hold office up-to the date of the ensuing Annual General Meeting of the Company. If approved by the shareholders at the AGM, Mr. Raja Venkataraman will continue as Independent Director on the Board of the Company for a period of five years with effect from 27/05/2021.27-05-2021
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for quarter and year ended 31/03/202127-05-2021
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance report for 31/03/202127-05-2021
Amrutanjan Health Care Ltd - 590006 - Board recommends Final Dividend
Amrutanjan Health Care Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2021, inter alia, has recommended Final Dividend of Rs. 2.60 per equity share on 2,92,30,630 shares of Re. 1 each fully paid up for the financial year 2020-21. The Final dividend if approved at the Annual General Meeting will be paid to eligible shareholders within 30 days of AGM.27-05-2021
Amrutanjan Health Care Ltd - 590006 - Outcome Of Board Meeting
In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we wish to inform that the Board of Directors of the Company at its meeting held today (May 27, 2021) has inter-alia: (i) Approved the Audited Financial Results for the quarter and year ended March 31, 2021, as recommended by the Audit Committee at its meeting held today (May 27 2021)The same along with the Independent Auditor's Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company is enclosed. (ii) Recommended Final Dividend of Rs. 2.60 per equity share on 2,92,30,630 shares of Re. 1 each fully paid up for the financial year 2020-21. The Final dividend if approved at the Annual General Meeting will be paid to eligible shareholders within 30 days of AGM. (iii) Approved appointment of Mr. RAJA VENKATARAMAN (DIN: 00669376) as an Additional Director (Non-Executive & Independent) of the Company with effect from 27-05-202127-05-2021
Amrutanjan Health Care Ltd - 590006 - Board to consider Final Dividend
With reference to the earlier letter dated May 13, 2021, about the Board Meeting, Amrutanjan Health Care Ltd has now informed BSE that in the Board Meeting to be held on May 27, 2021, the Board will also consider Declaration of Final Dividend for the year 2020-21.18-05-2021
Amrutanjan Health Care Ltd - 590006 - Update on board meeting
AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2021 ,inter alia, to consider and approve This is to further inform that in the Board Meeting to be held on Thursday, the 27th May, 2021 thru Video Conferencing, the Board will also consider Declaration of Final Dividend for the year 2020-2118-05-2021
Amrutanjan Health Care Ltd - 590006 - Board Meeting Intimation for Audited Financial Results Along With The Audit Report By The Statutory Auditors For The Quarter And Year Ended March 31 2021
AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2021 ,inter alia, to consider and approve The Audited Financial Results along with the Audit Report by the Statutory Auditors for the quarter and year ended March 31 202113-05-2021